Precision BioSciences Inc (DTIL)
7.70
-0.38
(-4.70%)
USD |
NASDAQ |
Nov 14, 16:00
7.70
0.00 (0.00%)
After-Hours: 20:00
Precision BioSciences Cash and Short Term Investments (Quarterly): 101.20M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 101.20M |
June 30, 2024 | 123.57M |
March 31, 2024 | 137.77M |
December 31, 2023 | 116.68M |
September 30, 2023 | 122.23M |
June 30, 2023 | 137.79M |
March 31, 2023 | 158.13M |
December 31, 2022 | 189.58M |
September 30, 2022 | 212.05M |
June 30, 2022 | 184.14M |
March 31, 2022 | 116.22M |
December 31, 2021 | 143.66M |
Date | Value |
---|---|
September 30, 2021 | 160.47M |
June 30, 2021 | 173.94M |
March 31, 2021 | 193.46M |
December 31, 2020 | 89.80M |
September 30, 2020 | 104.15M |
June 30, 2020 | 126.89M |
March 31, 2020 | 154.19M |
December 31, 2019 | 180.89M |
September 30, 2019 | 206.26M |
June 30, 2019 | 226.10M |
March 31, 2019 | 116.50M |
December 31, 2018 | 103.19M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
89.80M
Minimum
Dec 2020
212.05M
Maximum
Sep 2022
146.34M
Average
140.73M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Assembly Biosciences Inc | 109.22M |
TG Therapeutics Inc | 341.04M |
Protagonist Therapeutics Inc | 468.72M |
Alector Inc | 457.20M |
Entrada Therapeutics Inc | 449.34M |